Biofrontera AG annual r&d spending
2021
2022
2023
2024
2025
Biofrontera AG R&D Spending Growth & History (B8FK)
Biofrontera AG's r&d spending was €2.2M for fiscal 2025.
View full Biofrontera AG company overviewBiofrontera AG annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.2M | −€3.1M | −58.30% |
| 2024 | 2024-12-31 | €5.4M | −€2.5M | −31.79% |
| 2023 | 2023-12-31 | €7.8M | €718,000 | +10.07% |
| 2022 | 2022-12-31 | €7.1M | €119,000 | +1.70% |
| 2021 | 2021-12-31 | €7.0M | — | — |
Biofrontera AG quarterly r&d spending
Q4.24
Q1.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | €539,000 | −€15,000 | −2.71% |
| Q4 2025 | 2025-12-31 | −€697,000 | −€1.5M | — |
| Q3 2025 | 2025-09-30 | €1.2M | — | — |
| Q1 2025 | 2025-03-31 | €554,000 | — | — |
| Q4 2024 | 2024-12-31 | €769,000 | — | — |
Biofrontera AG r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Biofrontera AG's r&d spending decreased from €7.0M to €2.2M, a change of −€4.8M. The latest reported quarter, Q1 2026, shows €539,000.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
reported R&D expense
TickerStat standardizes research and development expense reported in company official filings, including the software-specific standardized R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biofrontera AG source filings ↗